79 related articles for article (PubMed ID: 2557100)
1. [Increase in the number of alpha-2 adrenoceptors in blood platelets of patients with hypo-alpha-cholesterolemia].
Prusskikh GA; Shakhov IuA; Chudakova IA; Gratsianskiĭ NA; Oganov RG
Biull Eksp Biol Med; 1989 Oct; 108(10):423-6. PubMed ID: 2557100
[No Abstract] [Full Text] [Related]
2. LDL-cholesterol and HDL-cholesterol in ischaemic heart disease.
Atukorala TM; Gunarathna PH; Ekanayake RA; Wijayawardhana UD
Ceylon Med J; 1986 Mar; 31(1):9-14. PubMed ID: 3802308
[No Abstract] [Full Text] [Related]
3. [The amount of thrombocyte alpha 2-adrenoreceptors in patients with different clinical variants in the course of ischemic heart disease].
Prusskikh GA; Shartava ASh; Shakhov IuA; Gratsianskiĭ NA
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1989; 12(2):65-9. PubMed ID: 2557859
[TBL] [Abstract][Full Text] [Related]
4. Increased platelet cholesterol and decreased percentage volume of platelets as a secondary risk factor for coronary artery disease.
Ravindran R; Krishnan LK
Pathophysiol Haemost Thromb; 2007; 36(1):45-51. PubMed ID: 18332614
[TBL] [Abstract][Full Text] [Related]
5. [Influence of physical activity on plasma levels of lipids and lipoproteins in patients with coronary disease].
Da Silva MJ; Netto MP; Kedor HH; Camargo PA; Kiss MA; Giannini SD; Deperon SD
Arq Bras Cardiol; 1988 Apr; 50(4):231-6. PubMed ID: 3067692
[No Abstract] [Full Text] [Related]
6. New diagnostic tests for assessing coronary heart disease risk.
Naito HK
Prog Clin Biol Res; 1988; 255():49-62. PubMed ID: 3277204
[No Abstract] [Full Text] [Related]
7. [Serum lipids of alcoholics before and following abstinence. Significance for coronary risk].
Clemens MR; Schied HW; Waller HD
J Clin Chem Clin Biochem; 1986 Jun; 24(6):369-74. PubMed ID: 3746201
[TBL] [Abstract][Full Text] [Related]
8. Plasma HDL-cholesterol has an effect on nitric oxide production and arachidonic acid metabolism in the platelet membranes of coronary heart disease patients without LDL-hypercholesterolemia.
Tretjakovs P; Kalnins U; Dabina I; Dinne I; Erglis A; Kumsars I; Jurka A
Med Sci Monit; 2000; 6(3):507-11. PubMed ID: 11208362
[TBL] [Abstract][Full Text] [Related]
9. Serum-lipid and lipoprotein patterns of Beijing populations from birth to senescence.
Li JZ; Li PY; Niu QT; Wang S; Jiang L; Zhao SH; Guo HB; Gao H; Zhang ZM; Fang XZ
Chin Med J (Engl); 1988 Sep; 101(9):659-64. PubMed ID: 3148409
[No Abstract] [Full Text] [Related]
10. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).
Goldenberg I; Benderly M; Sidi R; Boyko V; Tenenbaum A; Tanne D; Behar S
Am J Cardiol; 2009 Jan; 103(1):41-5. PubMed ID: 19101227
[TBL] [Abstract][Full Text] [Related]
11. High-density lipoprotein cholesterol and triglycerides as therapeutic targets for preventing and treating coronary artery disease.
Gotto AM
Am Heart J; 2002 Dec; 144(6 Suppl):S33-42. PubMed ID: 12486414
[TBL] [Abstract][Full Text] [Related]
12. Search for an optimal atherogenic lipid risk profile: from the Framingham Study.
Nam BH; Kannel WB; D'Agostino RB
Am J Cardiol; 2006 Feb; 97(3):372-5. PubMed ID: 16442398
[TBL] [Abstract][Full Text] [Related]
13. [Cholesterol: how and when to treat it?].
Masana Marín L
Med Clin (Barc); 1985 Oct; 85(10):423-5. PubMed ID: 4079497
[No Abstract] [Full Text] [Related]
14. Cholesterol and coronary heart disease: predicting risks in men by changes in levels and ratios.
Kinosian B; Glick H; Preiss L; Puder KL
J Investig Med; 1995 Oct; 43(5):443-50. PubMed ID: 8528755
[TBL] [Abstract][Full Text] [Related]
15. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195
[TBL] [Abstract][Full Text] [Related]
16. [The lowering of serum cholesterol in the prevention of coronary disease (part 1). The Canadian Study Group for Periodic Medical Examinations].
Union Med Can; 1994 Apr; 123(4):249-58. PubMed ID: 8203048
[No Abstract] [Full Text] [Related]
17. Lipoproteins as predictors of ischemic heart disease in non-insulin-dependent diabetic men.
Barrett-Connor E; Philippi T; Khaw KT
Am J Prev Med; 1987; 3(4):206-10. PubMed ID: 3452358
[TBL] [Abstract][Full Text] [Related]
18. [Endothelial dysfunction and risk factors in coronary heart disease].
Filippov AE; Khandzhian AM; Salodukhin KA; Nikiforov VS; Bobkova OA
Klin Med (Mosk); 2006; 84(2):28-32. PubMed ID: 16613002
[TBL] [Abstract][Full Text] [Related]
19. Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol.
Bersot TP; Pépin GM; Mahley RW
Am Heart J; 2003 Dec; 146(6):1052-9. PubMed ID: 14660998
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular risk factor levels in adults with mental retardation.
Rimmer JH; Braddock D; Fujiura G
Am J Ment Retard; 1994 Jan; 98(4):510-8. PubMed ID: 8148127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
